Status:
COMPLETED
Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Sports Academy
Conditions:
COVID-19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To examine the efficacy of an 8-week exercise training program on functional, cognitive, and emotional health outcomes compared to a no treatment control condition in adults with PASC.
Detailed Description
Conduct a randomized control trial with a wait-list control to examine the efficacy of an 8-week exercise training program on functional, cognitive, and emotional health outcomes compared to a no trea...
Eligibility Criteria
Inclusion
- 18-65 years of age
- Self-reported history of COVID-19 diagnosis
- Self-reported ongoing symptoms of PASC \>4 weeks after initial infection
Exclusion
- Neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise or conditions preventing cooperation
- COVID-19 infection occurring \> 6 months prior to screening date
- Contraindications to Symptom-limited Maximal Exercise Testing
- Individuals without access to a device with iOS (apple devices such as iPhone, iPad, MacBook, etc.)
- Patient-reported diagnosis of severe arterial hypertension
- Patient reported metabolic disease
- Patient reported uncontrolled asthma
- Inmates
- Pregnancy
- Patient reported supplemental O2 use
- Presence of beards
- Patient reported diagnosis of claustrophobia
- Non-English speaking
Key Trial Info
Start Date :
April 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05218174
Start Date
April 22 2022
End Date
December 29 2023
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott and White Sports Therapy and Research
Frisco, Texas, United States, 75034